Charme Capital Partners acquires Prism Healthcare
Charme Capital Partners makes investment in Prism Healthcare, a leading UK provider of complex healthcare equipment and services, to support the Group’s further expansion in the UK and internationally.
London, 1 March 2022: Charme Capital Partners (“Charme”), the pan-European mid-market private equity firm, and Limerston Capital (“Limerston”) have announced that Charme IV has acquired Prism Healthcare (or “the Group”), a leading end-to-end provider of specialist healthcare equipment and services. As part of the transaction, Limerston will remain invested in the Group, providing long-term stability and support for Prism Healthcare’s continued development, while the management team will also retain a stake in the Group. Terms of the transaction were not disclosed.
Headquartered in Wakefield, Yorkshire, Prism Healthcare has a diverse portfolio of UK manufactured equipment, including safe patient handling, bathing, accessibility and pressure area care products. Its products provide healthcare professionals with affordable, clinically effective solutions to help disabled and mobility disadvantaged people remain mobile and active in their own homes, in long term care facilities or in acute care environments.
Prism Healthcare employs over 650 people and operates from nine UK locations, with a network of international distributors working across UK, EU and global markets. The Group’s customers include both public authorities and private providers, helping healthcare professionals provide excellent care, promote learning, aid movement or recovery, and support independence. Prism Healthcare develops, delivers, installs and services bespoke equipment that delivers vital improvements to the quality of life of its end users, with rapid response times enabled by its UK manufacturing footprint and nationwide team of engineers and assessors. The Group also has a strong product development pipeline, with a dedicated team continuously improving existing products and developing new ones to improve functionality for both users and carers.
Over the last three years, the business has doubled in size, successfully completing four add-on acquisitions, broadening its product range to become the most comprehensive in the country and expanding into new geographic areas to provide full UK coverage.
Charme’s investment will support the Group’s organic expansion through the continued development of its high-quality offering, to help more healthcare professionals provide the very best client care. Charme will also support the Group’s growth via acquisition, both in the UK and internationally.
Julian Huxtable, Partner at Charme Capital Partners, said: “We are delighted to be investing in Prism Healthcare and look forward to working closely with its management team to support the next phase of the Group’s expansion. Charme has proven expertise growing firms within the healthcare sector and, with local teams across Europe and extensive experience in internationalising businesses, we are well placed to help Prism Healthcare expand into new markets to bring its bespoke products and vital services to more customers.”
Paul Morton, CEO of Prism Healthcare, remarked: “We are thrilled to welcome Charme as a new investor in Prism Healthcare to support the Group’s continued development. We are confident that Charme is the right partner, with the right skills and experience, to help us realise our ambitious growth objectives. I would like to thank the team at Limerston Capital for their support in growing of the business over the past four years and I am delighted that they will remain an investor in the Group. We are excited to embark on a new chapter for Prism Healthcare, aimed at bringing our offering to more customers globally.”